Riskpilot← Back to searchSign inGet full accessSecway AB
ABActiveOrg 5592778913Hultgrens Väg 21Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20200 employees
Revenue 2025
SEK 788K
-7% vs 2024
EBITDA margin
-10.7%
+83% vs 2024
Equity ratio
41.7%
Financial strength
Net profit 2025
SEK -108K
+75% vs 2024
| Revenue | SEK 788K | -7% |
| EBITDA | SEK -84K | +83% |
| Net profit | SEK -108K | +75% |
| Total assets | SEK 472K | -23% |
| Equity | SEK 197K | -36% |
| Employees | 0 | — |
Legal name
Secway AB
Org number
5592778913
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
21 oktober 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska utveckla och marknadsföra produkter och tjänster samt bedriva konsultverksamhet inom områdena medicinteknik, digital teknik, digital säkerhet, samt därmed förenlig verksamhet.
Address
Hultgrens Väg 21
Email
anette@secway.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 34 | 1 327 | 2 136 | 844 | 788 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −4 | 252 | 824 | −500 | −84 |
| Depreciation & amort. | −0 | −0 | −34 | −34 | −34 |
| EBIT | −4 | 252 | 790 | −534 | −118 |
| Net financials | — | — | 4 | 8 | −9 |
| Profit before tax | −4 | 145 | 792 | −436 | −108 |
| Tax | −0 | −35 | −182 | −0 | −0 |
| Net profit | −4 | 110 | 610 | −436 | −108 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 49 | 1 277 | 1 257 | 613 | 472 |
| Equity | 22 | 131 | 742 | 306 | 197 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 28 | 1 038 | 406 | 288 | 275 |
| Total debt | 28 | 1 038 | 406 | 288 | 275 |
EBITDA margin
-10.7%
This company
15.8%
Market median
-168% vs market
20212025
Equity ratio
41.7%
This company
38.2%
Market median
+9% vs market
20212025
Return on equity
-54.8%
This company
18.4%
Market median
-398% vs market
20212025
Net profit margin
-13.7%
This company
8.1%
Market median
-269% vs market
20212025
Asset turnover
1.67×
This company
1.12×
Market median
+49% vs market
20212025
Debt / equity
1.40×
This company
0.62×
Market median
-126% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
SH Chief Auditor | Chief Auditor | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Secway AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Helena Katarina Nilsson | Chief Auditor | 0 companies |
| Karin Anette Cecilia Gullberg | Deputy Board Member | 0 companies |
| Johanna Antonia Gullberg | Deputy Board Member | 0 companies |
| Peter Gullberg | Board of Directors | 0 companies |